Related Experiment Video
Updated: Aug 8, 2026

07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Hypertension, hypertrophy, hormones, and the heart
1Division of Clinical Pharmacology, University of South Florida College of Medicine, Tampa, USA.
American Heart Journal
|March 6, 1998
Summary
Hypertension management aims to reduce cardiovascular risks. However, blood pressure levels don't fully predict complications, necessitating a deeper understanding of mitigating factors in treating hypertension.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Mild-to-moderate hypertension is prevalent, with known links to left ventricular hypertrophy, insulin resistance, and renal dysfunction.
- Elevated blood pressure increases the risk of atherosclerotic cardiovascular disease and ventricular arrhythmias.
- Current understanding suggests some independence between blood pressure levels and cardiovascular complications.
Purpose of the Study:
- To review the relationship between blood pressure and cardiovascular outcomes.
- To explore factors that mitigate the impact of hypertension on cardiovascular health.
- To update information on hypertension treatment and its effect on diverse cardiovascular outcomes.
Main Methods:
- Literature review of existing studies on hypertension and cardiovascular disease.
- Analysis of the association between blood pressure, intermediate risk factors, and clinical outcomes.
- Examination of therapeutic interventions and their impact on pressure-related versus atherosclerotic outcomes.
Main Results:
- Therapeutic interventions effectively reduce pressure-related outcomes like stroke.
- A similar reduction in atherosclerotic outcomes has not been consistently demonstrated.
- The level of blood pressure elevation does not reliably predict cardiovascular complications.
Conclusions:
- The relationship between blood pressure and cardiovascular outcomes is complex and influenced by various factors.
- Further research is needed to understand and address the gap in reducing atherosclerotic outcomes despite blood pressure control.
- Identifying and targeting mitigating factors is crucial for comprehensive hypertension management and cardiovascular risk reduction.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...

